article thumbnail

Cell and Gene Therapy Bioassay – A Prerequisite for the ATMPs Development

Roots Analysis

Bioassay – A Prerequisite for the Cell and Gene Therapy Development. Therefore, increase in development of cell and gene therapy domain has led to the rise in demand of bioassay services for cell and gene therapy. Bioassays are biochemical procedures that are used to evaluate the potency, purity and efficacy of a drug substance.

article thumbnail

Evaluating methods targeting Protein-Protein Interactions

pharmaphorum

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. PPIs are an integral part of the physiology of living organisms, as complexes which control biological pathways mediated by proteins. These regions are critical for optimal interactions between proteins.

Protein 125
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exclusive event: Accelerate the development of advanced biotherapeutics

Drug Discovery World

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity.

article thumbnail

Latest eBook – Make the switch to label-free interaction analysis

Drug Discovery World

The latest Creoptix eBook reveals the challenges presented by conventional label-based bioassays and explores how label-free interaction analysis can deliver a world of insight. Conventional bioassays rely on enzyme or fluorescent labels to detect biomolecular interactions.

article thumbnail

How ML and automation are changing the future of protein therapeutics

Drug Discovery World

Proteins are the basic building blocks and engines of biology. For decades, drug discovery and development have been constrained by limits in our knowledge of the relationship between protein sequence, structure and function, and the methods available to explore novel drug targets.

Protein 52
article thumbnail

Make the switch to label-free interaction analysis

Drug Discovery World

Conventional bioassays rely on enzyme or fluorescent labels to detect biomolecular interactions. More sensitive analysis – enabling close observation of small and fragment molecules and proteins in complex matrices. More sensitive analysis – enabling close observation of small and fragment molecules and proteins in complex matrices.

article thumbnail

At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector

Roots Analysis

You may also be interested in the following titles: Targeted protein degradation market , 2022-2035. Cell and Gene Therapy Bioassay Services Market, 2021-2030. Further, owing to the various advantages offered by the AHST, such as cost effectiveness, the demand for such kits is likely to increase in the coming years.